Jackson Square Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Jackson Square Capital's AMGN Position: Q2 2026 in Review
Jackson Square Capital reduced its Amgen (AMGN) stake by 6.5% in Q2 2026, selling an estimated $28.4K and leaving 1,195 shares worth $433K. The position accounts for 0.06% of the portfolio, ranked #107.
Jackson Square Capital first reported a position in AMGN in Q4 2019 and has held it in 6 quarters since. The position peaked at $450K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Jackson Square Capital held 1,195 shares of Amgen worth $433K as of Q2 2026.
- Jackson Square Capital sold 83 Amgen shares in Q2 2026, an estimated $28.4K.
- Amgen made up 0.06% of Jackson Square Capital's portfolio in Q2 2026, its #107 holding.
- Jackson Square Capital first reported a position in Amgen in Q4 2019 and has held it in 6 quarters since.
- Jackson Square Capital's Amgen position peaked at $450K in Q1 2026.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.